The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 120:592-594, December 1963
doi: 10.1176/appi.ajp.120.6.592
© 1963 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by AYD, F. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by AYD, F. J., JR.

PROLONGED PERPHENAZINE THERAPY AND THYROID FUNCTION

FRANK J. AYD JR. M.D.

The findings in this survey do not support those reported by Cranswick, et al. The slight deviations from normal values in 3 of 25 patients (1 below normal and 2 above) are clinically and statistically insignificant. On the basis of the PBI determinations in these 25 patients on longterm perphenazine therapy, it may be concluded that this phenothiazine has no direct or indirect pathological influence on the thyroid gland.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
D. Kohen and H. J. Wildgust
The evolution of hyperprolactinaemia as an entity in psychiatric patients
J Psychopharmacol, February 1, 2008; 22(2_suppl): 6 - 11.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1963 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org